Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
J Exp Med ; 216(4): 936-949, 2019 04 01.
Article in English | MEDLINE | ID: mdl-30886059

ABSTRACT

Diabetic nephropathy is a leading cause of end-stage kidney failure. Reduced angiopoietin-TIE2 receptor tyrosine kinase signaling in the vasculature leads to increased vascular permeability, inflammation, and endothelial cell loss and is associated with the development of diabetic complications. Here, we identified a mechanism to explain how TIE2 signaling is attenuated in diabetic animals. Expression of vascular endothelial protein tyrosine phosphatase VE-PTP (also known as PTPRB), which dephosphorylates TIE2, is robustly up-regulated in the renal microvasculature of diabetic rodents, thereby reducing TIE2 activity. Increased VE-PTP expression was dependent on hypoxia-inducible factor transcriptional activity in vivo. Genetic deletion of VE-PTP restored TIE2 activity independent of ligand availability and protected kidney structure and function in a mouse model of severe diabetic nephropathy. Mechanistically, inhibition of VE-PTP activated endothelial nitric oxide synthase and led to nuclear exclusion of the FOXO1 transcription factor, reducing expression of pro-inflammatory and pro-fibrotic gene targets. In sum, we identify inhibition of VE-PTP as a promising therapeutic target to protect the kidney from diabetic injury.


Subject(s)
Diabetic Nephropathies/metabolism , Receptor, TIE-2/metabolism , Receptor-Like Protein Tyrosine Phosphatases, Class 3/genetics , Animals , Cell Line , Disease Models, Animal , Endothelial Cells/metabolism , Endothelium, Vascular/metabolism , Forkhead Box Protein O1/metabolism , Gene Knockdown Techniques , Humans , Kidney/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Nitric Oxide Synthase/metabolism , RNA, Small Interfering/genetics
2.
Int J Mol Sci ; 20(2)2019 01 21.
Article in English | MEDLINE | ID: mdl-30669557

ABSTRACT

Arf GTPase-activating proteins (Arf GAPs) control the activity of ADP-ribosylation factors (Arfs) by inducing GTP hydrolysis and participate in a diverse array of cellular functions both through mechanisms that are dependent on and independent of their Arf GAP activity. A number of these functions hinge on the remodeling of actin filaments. Accordingly, some of the effects exerted by Arf GAPs involve proteins known to engage in regulation of the actin dynamics and architecture, such as Rho family proteins and nonmuscle myosin 2. Circular dorsal ruffles (CDRs), podosomes, invadopodia, lamellipodia, stress fibers and focal adhesions are among the actin-based structures regulated by Arf GAPs. Arf GAPs are thus important actors in broad functions like adhesion and motility, as well as the specialized functions of bone resorption, neurite outgrowth, and pathogen internalization by immune cells. Arf GAPs, with their multiple protein-protein interactions, membrane-binding domains and sites for post-translational modification, are good candidates for linking the changes in actin to the membrane. The findings discussed depict a family of proteins with a critical role in regulating actin dynamics to enable proper cell function.


Subject(s)
ADP-Ribosylation Factors/metabolism , Actin Cytoskeleton/metabolism , GTPase-Activating Proteins/metabolism , ADP-Ribosylation Factors/chemistry , Actin Cytoskeleton/chemistry , Actins/chemistry , Actins/metabolism , Animals , Apoptosis , Cell Movement , Focal Adhesions , GTPase-Activating Proteins/chemistry , GTPase-Activating Proteins/genetics , Host-Pathogen Interactions , Humans , Multigene Family , Neuronal Outgrowth , Neurons/metabolism , Podosomes/metabolism , Protein Binding , Pseudopodia/metabolism , Structure-Activity Relationship , rho GTP-Binding Proteins/genetics , rho GTP-Binding Proteins/metabolism
3.
J Am Soc Nephrol ; 29(4): 1097-1107, 2018 04.
Article in English | MEDLINE | ID: mdl-29237738

ABSTRACT

Urinary concentrating ability is central to mammalian water balance and depends on a medullary osmotic gradient generated by a countercurrent multiplication mechanism. Medullary hyperosmolarity is protected from washout by countercurrent exchange and efficient removal of interstitial fluid resorbed from the loop of Henle and collecting ducts. In most tissues, lymphatic vessels drain excess interstitial fluid back to the venous circulation. However, the renal medulla is devoid of classic lymphatics. Studies have suggested that the fenestrated ascending vasa recta (AVRs) drain the interstitial fluid in this location, but this function has not been conclusively shown. We report that late gestational deletion of the angiopoietin receptor endothelial tyrosine kinase 2 (Tie2) or both angiopoietin-1 and angiopoietin-2 prevents AVR formation in mice. The absence of AVR associated with rapid accumulation of fluid and cysts in the medullary interstitium, loss of medullary vascular bundles, and decreased urine concentrating ability. In transgenic reporter mice with normal angiopoietin-Tie2 signaling, medullary AVR exhibited an unusual hybrid endothelial phenotype, expressing lymphatic markers (prospero homeobox protein 1 and vascular endothelial growth factor receptor 3) as well as blood endothelial markers (CD34, endomucin, platelet endothelial cell adhesion molecule 1, and plasmalemmal vesicle-associated protein). Taken together, our data redefine the AVRs as Tie2 signaling-dependent specialized hybrid vessels and provide genetic evidence of the critical role of AVR in the countercurrent exchange mechanism and the structural integrity of the renal medulla.


Subject(s)
Angiopoietin-1/physiology , Angiopoietin-2/physiology , Extracellular Fluid/metabolism , Kidney Concentrating Ability/physiology , Kidney Medulla/blood supply , Receptor, TIE-2/physiology , Angiopoietin-1/deficiency , Angiopoietin-1/genetics , Angiopoietin-2/deficiency , Angiopoietin-2/genetics , Animals , Body Patterning , Cell Lineage , Endothelium, Vascular , Genes, Reporter , Gestational Age , Homeodomain Proteins/analysis , Kidney Diseases, Cystic/genetics , Kidney Medulla/embryology , Kidney Medulla/physiology , Mice , Mice, Knockout , Mice, Transgenic , Myofibroblasts/pathology , Osmosis , Receptor, TIE-2/deficiency , Receptor, TIE-2/genetics , Renal Circulation , Signal Transduction , Tumor Suppressor Proteins/analysis , Vascular Endothelial Growth Factor Receptor-3/analysis
4.
J Clin Invest ; 127(12): 4421-4436, 2017 12 01.
Article in English | MEDLINE | ID: mdl-29106382

ABSTRACT

Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm's canal (SC) and the trabecular meshwork. We previously identified loss-of-function mutations in the angiopoietin (ANGPT) receptor TEK in families with PCG and showed that ANGPT/TEK signaling is essential for SC development. Here, we describe roles for the major ANGPT ligands in the development of the aqueous outflow pathway. We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure. By contrast, ANGPT2 was dispensable, although mice deficient in both Angpt1 and Angpt2 completely lacked SC, indicating that ANGPT2 compensates for the loss of ANGPT1. In addition, we identified 3 human subjects with rare ANGPT1 variants within an international cohort of 284 PCG patients. Loss of function in 2 of the 3 patient alleles was observed by functional analysis of ANGPT1 variants in a combined in silico, in vitro, and in vivo approach, supporting a causative role for ANGPT1 in disease. By linking ANGPT1 with PCG, these results highlight the importance of ANGPT/TEK signaling in glaucoma pathogenesis and identify a candidate target for therapeutic development.


Subject(s)
Angiopoietin-1/metabolism , Lymphatic Vessels/embryology , Signal Transduction , Angiopoietin-1/genetics , Animals , Cohort Studies , Female , Genetic Diseases, Inborn/embryology , Genetic Diseases, Inborn/genetics , Glaucoma/embryology , Glaucoma/genetics , Humans , Lymphatic Vessels/pathology , Male , Mice , Mice, Knockout , Receptor, TIE-2/genetics , Receptor, TIE-2/metabolism , Trabecular Meshwork/embryology , Trabecular Meshwork/pathology
SELECTION OF CITATIONS
SEARCH DETAIL